Q-omics provides the consensus-scored SNX5P2 profile across patient tissues and cancer cell-line models. SNX5P2 expression is associated with patient survival in 20 of 34 cancer types, with the highest sampling consensus in OV. Among the 18 cancer types available for tumor–normal comparison, SNX5P2 is differentially expressed in 5, with the highest sampling consensus in COAD. Additionally, SNX5P2 RNA expression shows 14,768 significant protein co-abundance associations, with the highest sampling consensus in GBM. Together, these results highlight OV, COAD, and GBM as cancer lineages where SNX5P2 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for SNX5P2 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes SNX5P2 survival associations across molecular data types. SNX5P2 RNA expression shows survival associations in the most cancer types (20). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible SNX5P2 RNA expression–survival associations across cancer types. High SNX5P2 expression shows unfavorable associations in OV, UVM and DLBC, but favorable associations in KIRP, KIRC and THYM. The OV Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .005). Together, the overview and detailed table identify OV as the clearest survival context for SNX5P2 RNA expression.
This table summarizes SNX5P2 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 5. The strongest signals are observed in COAD for RNA.
This table ranks reproducible tumor–normal expression differences for SNX5P2. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. SNX5P2 shows higher tumor expression in COAD, KICH, READ, LUAD and LIHC. The COAD box plot shows higher SNX5P2 RNA expression in tumor versus normal tissue (log2 FC = +0.188, t-test p = .003).
This table shows molecular features associated with SNX5P2 in patient tissues and cancer cell lines. In patient samples, SNX5P2 shows the broadest associations at the RNA and protein expression levels, with GBM recurring as the lineage with the largest associated feature set.
